Monocyte‐related cytokines/chemokines in cerebral ischemic stroke

M Bai, R Sun, B Cao, J Feng… - CNS Neuroscience & …, 2023 - Wiley Online Library
Aims Ischemic stroke is one of the leading causes of death worldwide and the most common
cause of disability in Western countries. Multiple mechanisms contribute to the development …

The involvement and therapy target of immune cells after ischemic stroke

Z Jian, R Liu, X Zhu, D Smerin, Y Zhong, L Gu… - Frontiers in …, 2019 - frontiersin.org
After ischemic stroke, the integrity of the blood-brain barrier is compromised. Peripheral
immune cells, including neutrophils, T cells, B cells, dendritic cells, and macrophages …

The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke

TY Lei, YZ Ye, XQ Zhu, D Smerin, LJ Gu… - Journal of …, 2021 - Springer
Through considerable effort in research and clinical studies, the immune system has been
identified as a participant in the onset and progression of brain injury after ischaemic stroke …

Immunoinflammatory background of neuronal damage in stroke

A Tuttolomondo - International Journal of Molecular Sciences, 2023 - mdpi.com
Ischemic stroke is caused by a reduction in blood flow to the brain and is a major cause of
mortality and disability worldwide. Cerebral ischemia initiates a complex cascade of events …

[HTML][HTML] The role of monocytes in ischemic stroke pathobiology: new avenues to explore

A ElAli, N Jean LeBlanc - Frontiers in aging neuroscience, 2016 - frontiersin.org
Ischemic stroke accounts for the majority of stroke cases and constitutes a major cause of
death and disability in the industrialized world. Inflammation has been reported to constitute …

Systemic immune responses after ischemic stroke: from the center to the periphery

F Wu, Z Liu, L Zhou, D Ye, Y Zhu, K Huang… - Frontiers in …, 2022 - frontiersin.org
Ischemic stroke is a leading cause of disability and death. It imposes a heavy economic
burden on individuals, families and society. The mortality rate of ischemic stroke has …

Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato… - PLoS one, 2013 - journals.plos.org
Background and Purpose The most common strategy for treating patients with acute
ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because …

Role of bone marrow-derived macrophages (BMDMs) in neurovascular interactions during stroke

A Srivastava, P Srivastava, R Verma - Neurochemistry International, 2019 - Elsevier
Stroke is a leading cause of disability worldwide and hence remains a major medical
concern. Besides several pathological features, such as excitotoxicity, peri-infarct …

Contrasting roles of immune cells in tissue injury and repair in stroke: The dark and bright side of immunity in the brain

A Rayasam, M Hsu, G Hernández, J Kijak… - Neurochemistry …, 2017 - Elsevier
Despite considerable efforts in research and clinical studies, stroke is still one of the leading
causes of death and disability worldwide. Originally, stroke was considered a vascular …

Role of immune and inflammatory mechanisms in stroke: a review of current advances

H Zhao, Y Li, Y Zhang, WY He, WN Jin - Neuroimmunomodulation, 2022 - karger.com
Stroke accounts for a large proportion of morbidity and mortality burden in China. Moreover,
there is a high prevalence of the leading risk factors for stroke, including hypertension and …